ATCAY
Basic information
Region (hg38): 19:3879864-3928082
Links
Phenotypes
GenCC
Source:
- Cayman type cerebellar ataxia (Supportive), mode of inheritance: AR
- Cayman type cerebellar ataxia (Moderate), mode of inheritance: AR
- Cayman type cerebellar ataxia (Strong), mode of inheritance: AR
- cerebellar ataxia (Definitive), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Ataxia, cerebellar, Cayman type | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Neurologic | 14556008 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (2 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ATCAY gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 16 | |||||
missense | 51 | 52 | ||||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 3 | 4 | 1 | 9 | |
non coding | 72 | 14 | 27 | 113 | ||
Total | 1 | 0 | 130 | 23 | 28 |
Variants in ATCAY
This is a list of pathogenic ClinVar variants found in the ATCAY region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
19-3880620-AC-A | Cayman type cerebellar ataxia | Likely benign (Jun 14, 2016) | ||
19-3880652-C-A | Cayman type cerebellar ataxia | Likely benign (Jan 12, 2018) | ||
19-3880660-A-G | Cayman type cerebellar ataxia | Benign (Jan 13, 2018) | ||
19-3880675-G-T | Cayman type cerebellar ataxia | Uncertain significance (Jun 14, 2016) | ||
19-3880809-C-T | Cayman type cerebellar ataxia | Benign (Jan 13, 2018) | ||
19-3880852-C-G | Cayman type cerebellar ataxia | Uncertain significance (Jan 13, 2018) | ||
19-3880874-C-T | Cayman type cerebellar ataxia | Uncertain significance (Mar 30, 2018) | ||
19-3880880-C-A | Cayman type cerebellar ataxia | Uncertain significance (Jan 12, 2018) | ||
19-3884705-G-A | Cayman type cerebellar ataxia | Uncertain significance (Mar 16, 2021) | ||
19-3885714-G-A | Cayman type cerebellar ataxia | Uncertain significance (Jan 12, 2018) | ||
19-3885778-C-T | Inborn genetic diseases | Uncertain significance (Jul 25, 2023) | ||
19-3885803-C-T | Cayman type cerebellar ataxia | Conflicting classifications of pathogenicity (Mar 01, 2024) | ||
19-3885826-A-T | Inborn genetic diseases | Uncertain significance (Dec 19, 2023) | ||
19-3902504-C-T | Uncertain significance (Feb 01, 2022) | |||
19-3902505-G-A | Likely benign (Oct 23, 2018) | |||
19-3902506-G-A | Inborn genetic diseases | Uncertain significance (Jun 08, 2022) | ||
19-3902507-G-A | Cayman type cerebellar ataxia • Inborn genetic diseases | Conflicting classifications of pathogenicity (Jun 13, 2024) | ||
19-3902528-C-T | Inborn genetic diseases | Uncertain significance (May 28, 2024) | ||
19-3905423-T-C | Cayman type cerebellar ataxia | Likely benign (Apr 27, 2017) | ||
19-3905449-T-C | Inborn genetic diseases | Uncertain significance (Mar 18, 2024) | ||
19-3905459-C-T | Cayman type cerebellar ataxia | Conflicting classifications of pathogenicity (Jan 13, 2018) | ||
19-3905496-G-C | Inborn genetic diseases | Uncertain significance (Jul 02, 2024) | ||
19-3905498-G-A | Likely benign (Apr 12, 2018) | |||
19-3905514-G-A | Inborn genetic diseases | Uncertain significance (Jul 26, 2024) | ||
19-3905527-G-C | Inborn genetic diseases | Uncertain significance (Jun 07, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ATCAY | protein_coding | protein_coding | ENST00000450849 | 12 | 48216 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.621 | 0.379 | 124629 | 0 | 6 | 124635 | 0.0000241 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.61 | 185 | 258 | 0.718 | 0.0000178 | 2451 |
Missense in Polyphen | 64 | 110.22 | 0.58063 | 1023 | ||
Synonymous | -0.414 | 116 | 110 | 1.05 | 0.00000892 | 692 |
Loss of Function | 3.38 | 4 | 20.5 | 0.195 | 8.77e-7 | 234 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000647 | 0.0000646 |
Ashkenazi Jewish | 0.0000998 | 0.0000994 |
East Asian | 0.00 | 0.00 |
Finnish | 0.0000929 | 0.0000928 |
European (Non-Finnish) | 0.0000192 | 0.0000177 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Functions in the development of neural tissues, particularly the postnatal maturation of the cerebellar cortex. May play a role in neurotransmission through regulation of glutaminase/GLS, an enzyme responsible for the production in neurons of the glutamate neurotransmitter. Alternatively, may regulate the localization of mitochondria within axons and dendrites. {ECO:0000269|PubMed:16899818}.;
- Disease
- DISEASE: Cerebellar ataxia, cayman type (ATCAY) [MIM:601238]: Found in a population isolate on Grand Cayman Island and causes a marked psychomotor retardation and prominent nonprogressive cerebellar dysfunction including nystagmus, intention tremor, dysarthria, and wide-based ataxic gait. Hypotonia is present from early childhood. {ECO:0000269|PubMed:14556008}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Intolerance Scores
- loftool
- 0.406
- rvis_EVS
- -0.54
- rvis_percentile_EVS
- 20.54
Haploinsufficiency Scores
- pHI
- 0.199
- hipred
- Y
- hipred_score
- 0.774
- ghis
- 0.604
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.152
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Atcay
- Phenotype
- endocrine/exocrine gland phenotype; growth/size/body region phenotype; homeostasis/metabolism phenotype; muscle phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); immune system phenotype;
Zebrafish Information Network
- Gene name
- atcaya
- Affected structure
- motor neuron
- Phenotype tag
- abnormal
- Phenotype quality
- decreased length
Gene ontology
- Biological process
- polyphosphate catabolic process;apoptotic process;neuron projection development;regulation of protein localization;mitochondrion distribution;negative regulation of glutamate metabolic process
- Cellular component
- cytoplasm;mitochondrion;cell junction;axon;dendrite;mitochondrial membrane;neuron projection;synapse
- Molecular function
- exopolyphosphatase activity;protein binding;kinesin binding;WW domain binding